Targeted Drug Delivery Device Market Growth

Targeted Drug Delivery Device Market Size to reach USD 2,153 million by 2035 | Roots Analysis

Given the rapid pace of growth within the biopharmaceutical market, the demand for effective delivery systems is anticipated to increase in the foreseen future. This is likely to create lucrative opportunities for stakeholders in the targeted drug delivery devices market.

Targeted Drug Delivery Device Market Overview

The global Targeted Drug Delivery Device Market is expected to reach USD 2,153 million by 2035, growing at a CAGR of 19.7% during the forecast period, till 2035.

The pharmaceutical industry is increasingly moving towards biologics from traditional small molecule drugs. This is primarily because of the specificity and efficacy of biologics that makes them proficient in treating complex diseases. Since, it has become increasingly popular because it offers many benefits still biologics poses various challenges, such as drug delivery-related complications along with immunogenicity.

To overcome these challenges, the pharmaceutical industry is focusing on the development of targeted drug delivery devices that will improve the therapeutic safety index and enhance the delivery of therapies to the targeted site. Targeted drug delivery device enables the administration of drugs to specific areas, thereby enhancing efficacy and reducing systemic toxicity. Site-specific drug delivery needs are one of the factors that push forward newer innovative drug delivery technologies and devices. Considering that biologics pose an inherent delivery challenge, there is a ongoing need for targeted drug delivery devices. Therefore, the companies are actively engaged in manufacturing targeted drug delivery devices that can optimize drug efficacy and safety.

Browse 100+ figures and 120+ market data tables spread across 270+ pages and detailed Table of Content on “Targeted Drug Delivery Device Market: Industry Trends and Global Forecasts, till 2035 by Distribution by Type of Device (Catheters, Cannulas and Others), Target Organ (Brain, Breast, Eyes and Heart), Type of Therapy Delivered (Cell Therapies, Gene Therapies and Immunotherapies), Route of Administration (Intratumoral, Transendocardial and Others), Therapeutic Area (Cardiovascular Disorders, Oncological Disorders, Ophthalmic Disorders and Neurological Disorders), Key Geographical Regions (North America, Europe and Asia-Pacific), Leading Players and Sales Forecast” here: https://www.rootsanalysis.com/reports/targeted-drug-delivery.html

Market Drivers

Several factors are propelling the targeted drug delivery device market growth. One of the key factors driving the future growth of this market is growing demand for personalized medicines. With the ongoing shift towards personalized treatment approaches in healthcare, there is a growing need for drug delivery devices that can cater to individual patient profiles. These devices enhance treatment outcomes by delivering precise dosage of medications directly to specific organs, thereby improving therapeutic efficacy and patient compliance.

Market Restraints

While the targeted drug delivery device market is experiencing substantial growth, there are certain restraints that can hinder the growth of this industry. One of the primary restraints include the high development cost of these devices. The development of targeted drug delivery devices involves substantial investments in research and development, manufacturing, regulatory compliance and conduct of extensive clinical trials. This financial burden often discourages potential investors / start-ups, restricting innovation and limiting the introduction of novel therapies. Consequently, these high costs associated with development of targeted drug delivery devices not only hinder market growth, but also limit access to potentially life-saving treatments.

Growth Factors

The targeted drug delivery device market growth is attributed to several key factors. One such factor is rise in research and development activities. The increase in R&D investments presents a significant opportunity for developers in the targeted drug delivery device market. This growth is largely fueled by the rising incidence of chronic diseases and the growing demand for innovative therapies. Additionally, recent funding initiatives underscore the industry's inclination towards innovation, enabling developers to address challenges associated with drug delivery and enhance treatment efficacy.

Targeted Drug Delivery Device Market Segments

Based on the type of device, the market is segmented into cannulas, catheters and others

• The cannula segment is likely to capture the largest revenue share of more than 90% in the targeted drug delivery device market, in 2026.
• The catheter segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 23.5% during the forecast period.

Based on the target organ, the market is segmented into breast, brain, heart and eyes

• The breast segment is likely to capture the largest revenue share of close to 75% in the targeted drug delivery device market, in 2026.
• The heart segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 23.5% during the forecast period.

Based on the type of therapy delivered, the market is segmented into immunotherapies, gene therapies and cell therapies

• The immunotherapies segment is likely to capture the largest revenue share of over 80% in the targeted drug delivery device market, in 2026.
• The cell therapies segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 28.6% during the forecast period.

Based on the route of administration, the market is segmented into intratumorals, transendocardials and others

• The intratumorals segment is likely to capture the largest revenue share of over 80% in the targeted drug delivery device market, in 2026.
• The others segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 30.4% during the forecast period.

Based on the therapeutic area, the market is segmented into oncological disorders, cardiovascular disorders, neurological disorders and ophthalmic disorders

• The oncological disorders segment is likely to capture the largest revenue share of over 80% in the targeted drug delivery device market, in 2026.
• The cardiovascular disorders segment is anticipated to be the fastest growing segment in this industry, with an annualized rate (CAGR) of 23.5% during the forecast period.

Based on key geographical regions, the market is segmented North America, Europe and Asia-Pacific

• North America dominated the targeted drug delivery device market and is likely to account for the largest revenue share of over 75% in 2026.
• In Europe, targeted drug delivery device market is anticipated to demonstrate lucrative growth during the forecast period with a growth rate of 21.3%.

Key Companies Profiled

The targeted drug delivery device market report also includes detailed profiles of key players (listed below) that offer targeted drug delivery devices:

• Alcyone Lifesciences
• Algorae Pharmaceuticals
• BioCradia
• ClearPoint Neuro
• Gloriana Therapeutics
• Mercator MedSystems
• Neurotech Pharmaceuticals
• Novartis
• OncoSec
• PharmaCyte Biotech
• PulseSight Therapeutics
• Renishaw
• Silexion Therapeutics
• SmartCella

You Can Download Free Sample PDF Copy Of This Report At: https://www.rootsanalysis.com/reports/targeted-drug-delivery/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary

Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com